Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Pulse Biosciences, Inc. (PLSE)  
$7.82 0.23 (2.86%) as of 4:30 Fri 5/3


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 25,340,000
Market Cap: 198.16(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $3.85 - $12.84
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 21.4
Insider 3/6 Months : 22
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Pulse Biosciences is a bioelectric medicine company. The CellFX® System (CellFX) is the commercial product to harness the distinctive advantages of Co.'s proprietary Nano-Pulse Stimulation™ (NPS) technology, such as the ability to non-thermally clear cells while sparing non-cellular tissue, to treat a variety of conditions for which an optimal solution remains unfulfilled. The CellFX System is a tunable, software-enabled, console-based platform, designed to accommodate the clinical workflow preferred by physicians. Co. has also designed an integrated cloud software infrastructure called CellFX CloudConnect™. CellFX CloudConnect also facilitates direct connectivity to the CellFX System.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 1,060,434 11,083,371 11,120,651
Total Buy Value $0 $9,686,016 $74,935,336 $75,020,194
Total People Bought 0 3 3 3
Total Buy Transactions 0 16 17 20
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 128
  Page 2 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Duggan Robert W Director   –       •       •   2023-06-14 4 OE $2.05 $166,101 I/I 81,025 492,069     -
   Duggan Robert W Director   –       •       •   2023-06-14 4 OE $2.05 $11,650,484 D/D 5,683,163 36,097,824     -
   Uecker Darrin Chief Technology Officer   •       •      –    2023-06-12 4/A OE $2.05 $15,098 D/D 7,365 148,941     -
   Uecker Darrin Chief Technology Officer   •       •      –    2023-06-12 4 OE $2.05 $15,098 D/D 7,365 877,636     -
   Zanganeh Maky Director   •       •      –    2023-06-09 4/A OE $2.05 $177,669 D/D 86,668 528,836     -
   Zanganeh Maky Director   •       •      –    2023-06-09 4 OE $2.05 $177,669 D/D 86,668 791,915     -
   Levinson Mitchell E. Chief Strategy Officer   •       •      –    2023-05-25 4/A OE $2.05 $22,417 D/D 10,935 68,766     -
   Levinson Mitchell E. Chief Strategy Officer   •       •      –    2023-05-25 4 OE $2.05 $2,548 I/I 1,243 734     -
   Levinson Mitchell E. Chief Strategy Officer   •       •      –    2023-05-25 4 OE $2.05 $22,417 D/D 10,935 230,843     -
   Duggan Robert W Director   –       •       •   2023-05-09 4 B $6.51 $65,249,320 D/D 10,022,937 30,414,661 3.92 -45%     
   Levinson Mitchell E. Chief Strategy Officer   •       •      –    2022-10-07 4 B $2.23 $49,825 I/I 22,010 5,034 2.66 30%     
   Levinson Mitchell E. Chief Strategy Officer   •       •      –    2022-10-07 4 B $2.29 $20,083 D/D 8,770 46,274 2.81 30%     
   Danahy Kevin Patrick Chief Executive Officer   •       –      –    2022-09-30 4 B $2.30 $14,950 D/D 6,500 6,500 2.74 30%     
   Uecker Darrin Director   –       •      –    2022-06-09 4 OE $0.00 $0 D/D 7,365 137,376     -
   Levinson Mitchell E. Chief Strategy Officer   •       •      –    2022-06-09 4 OE $0.00 $0 I/I 1,243 734     -
   Levinson Mitchell E. Chief Strategy Officer   •       •      –    2022-06-09 4 OE $0.00 $0 D/D 10,935 37,504     -
   Zanganeh Maky Director   –       •      –    2022-06-09 4 OE $0.00 $0 D/D 86,668 442,168     -
   Duggan Robert W Director   –       •       •   2022-06-09 4 OE $0.00 $0 I/I 81,025 411,044     -
   Duggan Robert W Director   –       •       •   2022-06-09 4 OE $0.00 $0 D/D 5,683,163 20,391,724     -
   Duggan Robert W Director   –       •       •   2021-06-30 4 B $16.40 $49,999,992 D/D 3,048,780 14,708,561 3.92 43%     
   Ebbers Ed EVP & GM, Dermatology   •       –      –    2021-06-01 4 D $18.76 $27,859 D/D (1,485) 39,300     -
   Uecker Darrin CEO and President   •       •      –    2021-01-25 4 OE $7.01 $9,001 D/D 1,284 127,893     -
   Levinson Mitchell E. Director   –       •      –    2021-01-20 4 OE $7.01 $1,150 I/I 164 591     -
   Zanganeh Maky Director   –       •      –    2021-01-19 4 OE $7.01 $2,152 I/I 307 107,074     -
   Zanganeh Maky Director   –       •      –    2021-01-08 4 OE $7.01 $21,030 D/D 3,000 355,500     -
  128 Records found
  1  2  3  4  5  6   
  Page 2 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us